Skip to content

Preventive effect of atorvastatin in contarst nephropathy

Preventive Effect of Atorvastatin 80 mg on Contrast Induced Nephropathy after Angiography in High Risk Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014120117413N9
Enrollment
250
Registered
2014-12-15
Start date
2013-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast induced nephropathy. Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

Interventions

For the case group from 48 hours before performing angiography Atorvastatin 80 mg/day and for the control group placebo was prescribed. Then all of case and control groups recieved isotonic saline a
Treatment - Drugs

Sponsors

Baqiyatallah university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diabetes mellitus (FBS> 126, Random BS> 200, GTT> 200); chronic renal failure (creatinine higher than 1.5 mg/dl or GFR less than 60) Exclusion criteria: recent treatment with statin 80 mg; patients requiring emergency angiography; contraindications to prescribe statins; Patients with previous contrast media administration during the last 10 days; Patients with chronic dialysis treatment; patients with informed refusal of consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
BUN. Timepoint: before-24 hr and 48 hr after intervention. Method of measurement: blood sampling.;Creatinine. Timepoint: before-24 hr and 48 hr after intervention. Method of measurement: blood sampling.;HB. Timepoint: befor intervention. Method of measurement: blood sampling.;LVEF. Timepoint: befor intervention. Method of measurement: echocardiography.;Lipid profile. Timepoint: befor intervention. Method of measurement: blood sampling.;CIN. Timepoint: 24 hr and 48 hr after intervention. Method of measurement: an increasing serum creatinine more than 0.5mg/dl or more than 25% from the base.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHesam sadat Hashemi

Baqiyatallah university of medical science

seyyedhesam.hashemi@gmail.com+98 21 7710 4021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026